ATE538218T1 - Genexpressionssignaturen für chronische/sklerosierende allotransplantat- nephropathie - Google Patents

Genexpressionssignaturen für chronische/sklerosierende allotransplantat- nephropathie

Info

Publication number
ATE538218T1
ATE538218T1 AT08846586T AT08846586T ATE538218T1 AT E538218 T1 ATE538218 T1 AT E538218T1 AT 08846586 T AT08846586 T AT 08846586T AT 08846586 T AT08846586 T AT 08846586T AT E538218 T1 ATE538218 T1 AT E538218T1
Authority
AT
Austria
Prior art keywords
chronic
allotransplant
sclerosing
nephropathy
gene expression
Prior art date
Application number
AT08846586T
Other languages
English (en)
Inventor
Pierre Saint-Mezard
Hai Zhang
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Application granted granted Critical
Publication of ATE538218T1 publication Critical patent/ATE538218T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/136—Screening for pharmacological compounds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AT08846586T 2007-11-08 2008-11-06 Genexpressionssignaturen für chronische/sklerosierende allotransplantat- nephropathie ATE538218T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP07120263 2007-11-08
PCT/EP2008/065071 WO2009060035A1 (en) 2007-11-08 2008-11-06 Gene expression signatures for chronic/sclerosing allograft nephropathy

Publications (1)

Publication Number Publication Date
ATE538218T1 true ATE538218T1 (de) 2012-01-15

Family

ID=39144550

Family Applications (1)

Application Number Title Priority Date Filing Date
AT08846586T ATE538218T1 (de) 2007-11-08 2008-11-06 Genexpressionssignaturen für chronische/sklerosierende allotransplantat- nephropathie

Country Status (6)

Country Link
US (2) US20100233716A1 (de)
EP (2) EP2463383A3 (de)
JP (1) JP2011515068A (de)
AT (1) ATE538218T1 (de)
ES (1) ES2379673T3 (de)
WO (1) WO2009060035A1 (de)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX340916B (es) 2008-01-18 2016-07-29 President And Fellows Of Harvard College * Metodos para detectar señales de identificacion de enfermedad o condiciones en fluidos corporales.
WO2011006119A2 (en) 2009-07-09 2011-01-13 The Scripps Research Institute Gene expression profiles associated with chronic allograft nephropathy
JP2013509883A (ja) 2009-11-06 2013-03-21 ザ ボード オブ トラスティーズ オブ ザ リーランド スタンフォード ジュニア ユニバーシティ 臓器移植患者における移植片拒絶反応の非侵襲的診断方法
AU2016204268B2 (en) * 2009-12-23 2018-04-26 Hill's Pet Nutrition, Inc. Compositions and methods for diagnosing and treating kidney disorders in a canine
EP2596132A4 (de) 2010-07-23 2013-12-18 Harvard College Verfahren zur erkennung von anzeichen für krankheiten oder leiden in körperflüssigkeiten
TW201209171A (en) 2010-07-23 2012-03-01 Harvard College Methods of detecting diseases or conditions using phagocytic cells
CA2806296A1 (en) 2010-07-23 2012-01-26 President And Fellows Of Harvard College Methods of detecting kidney-associated diseases or conditions
US20130203624A1 (en) 2010-07-23 2013-08-08 President And Fellows Of Harvard College Methods of Detecting Prenatal or Pregnancy-Related Diseases or Conditions
AU2011280997A1 (en) 2010-07-23 2013-02-28 President And Fellows Of Harvard College Methods of detecting autoimmune or immune-related diseases or conditions
WO2014164362A1 (en) 2013-03-09 2014-10-09 Harry Stylli Methods of detecting prostate cancer
NZ771629A (en) 2013-03-09 2022-12-23 Harry Stylli Methods of detecting cancer
EP3611262B1 (de) 2013-03-15 2020-11-11 Lineage Biosciences, Inc. Verfahren zur sequenzierung des immunrepertoirs
GB2532672A (en) * 2013-09-09 2016-05-25 Scripps Research Inst Methods and systems for analysis of organ transplantation
WO2015179773A1 (en) 2014-05-22 2015-11-26 The Scripps Research Institute Tissue molecular signatures of kidney transplant rejections
US11104951B2 (en) 2014-05-22 2021-08-31 The Scripps Research Institute Molecular signatures for distinguishing liver transplant rejections or injuries
US10443100B2 (en) 2014-05-22 2019-10-15 The Scripps Research Institute Gene expression profiles associated with sub-clinical kidney transplant rejection
EP3146076A4 (de) 2014-05-22 2018-05-09 The Scripps Research Institute Mit subklinischer nierentransplantatabstossung assoziierte genexpressionsprofile
US10626464B2 (en) 2014-09-11 2020-04-21 Cell Mdx, Llc Methods of detecting prostate cancer
US20160224730A1 (en) * 2015-01-30 2016-08-04 RGA International Corporation Devices and methods for diagnostics based on analysis of nucleic acids
US20200174014A1 (en) 2016-12-19 2020-06-04 Osaka University METHOD FOR IN VITRO EARLY DIAGNOSIS OF ANTIBODY MEDIATED REJECTION AFTER ORGAN TRANSPLANTATION USING IgM-TYPE MEMORY B CELL DIFFERENTIATION CULTURE SYSTEM

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2070921A1 (de) 2000-11-07 2009-06-17 Novartis Ag Indolylmaleinimid-Derivate als Proteinkinase-C-Inhibitoren
TW200918046A (en) 2002-04-03 2009-05-01 Novartis Ag Indolylmaleimide derivatives
CA2506432A1 (en) 2002-12-09 2004-06-24 Robert A. Kirken Methods for selectively inhibiting janus tyrosine kinase 3 (jak3)
DK1704145T3 (da) 2004-01-12 2012-09-24 Ym Biosciences Australia Pty Selektive kinaseinhibitorer
GB0606776D0 (en) * 2006-04-03 2006-05-10 Novartis Pharma Ag Predictive biomarkers for chronic allograft nephropathy

Also Published As

Publication number Publication date
EP2463383A3 (de) 2012-10-17
ES2379673T3 (es) 2012-04-30
US20130072396A1 (en) 2013-03-21
WO2009060035A1 (en) 2009-05-14
EP2463383A2 (de) 2012-06-13
EP2209916A1 (de) 2010-07-28
EP2209916B1 (de) 2011-12-21
US20100233716A1 (en) 2010-09-16
JP2011515068A (ja) 2011-05-19

Similar Documents

Publication Publication Date Title
ATE538218T1 (de) Genexpressionssignaturen für chronische/sklerosierende allotransplantat- nephropathie
GB0607943D0 (en) Biomarkers for chronic transplant dysfunction
GB0606776D0 (en) Predictive biomarkers for chronic allograft nephropathy
WO2007104537A3 (en) Methods and compositions for assessing acute rejection
BRPI0919895A2 (pt) metodos para a separacao,caracterizacao e/ou identificacao de micro-organismos por espectroscopia,
EP2118864A4 (de) Verhaltenserkennungssystem
BRPI0919896A2 (pt) metodos para a separacao,caracterizacao e/ou identificacao de micro-organismos por espectroscopia de massa.
EP2115158A4 (de) Datenverarbeitung, analyseverfahren für genexpressionsdaten zur identifizierung endogener referenzgene
EP2464753A4 (de) Bioerkennungsverfahren und -zusammensetzungen
EP2183393A4 (de) miRNA-SIGNATUREN IN MENSCHLICHEM OVARIALKARZINOM
UA115321C2 (uk) Спосіб та комплект для аналізу ahasl генів у рослин
EP2611941A4 (de) Gensignaturen zur krebsdiagnose und -prognose
NO20092622L (no) Hydrokarbongassbearbeidng
EP2225649A4 (de) Speichersystem
WO2014015084A3 (en) System and methods for detecting genetic variation
EP2572355A4 (de) Aufnahme von textblöcken aus einem sprach-stream
BRPI0923159A2 (pt) gene de delta-endotoxina axmi-150 e métodos para sua utilização.
BRPI0922411A2 (pt) classificação de templates de ácido nucléico
GB2511690A (en) Detecting malware using stored patterns
EP2248024A4 (de) Speichersystem
EP2652623A4 (de) Vorrichtung, system, und verfahren für einen auto-commit-speicher
BRPI0819811A2 (pt) Identificação de setor usando assinaturas de parâmetros de setor
EP2807476A4 (de) Nachweis und sequenzierung von molekülen auf nanoporenbasis
EP2306934A4 (de) Verfahren und vorrichtung zum perkutanen austausch der aortenklappe
GB201319347D0 (en) Compositions and kits for molecular counting